Fig. 2: SULF1 was associated with the adverse clinicopathological characteristics and poor prognosis in GC.

IHC staining (A) and quantitative analysis result (B) of SULF1 in 80 paired GC and normal tissues. C qRT-PCR result of SULF1 mRNA expression in 80 paired GC and normal tissues. D Western blotting results of SULF1 expression in 8 paired GC and normal tissues. E Survival analysis of SULF1 in 80 GC patients using logrank test. F Differential analysis of SULF1 expression in TCGA, GSE65801 and GSE29272 datasets. G Two representative cases of gastric cancer patients with high and low expression of SULF1 who underwent PET-CT examination.